VXRT - What's Next for Vaxart After Its Massive Meltdown?
Vaxart (NASDAQ: VXRT) ranked as one of the hottest coronavirus stocks of 2020. Its share skyrocketed over 1,500% last year as investors became increasingly excited about the biotech's oral COVID-19 vaccine candidate, VXA-CoV2-1. As of the market close on Tuesday, Vaxart's share price had more than quadrupled year to date.
Then the dam burst. Vaxart stock lost more than half its value on Wednesday after the company announced disappointing preliminary phase 1 results for VXA-CoV2-1. What's next for Vaxart after its massive meltdown?
Image source: Getty Images.
For further details see:
What's Next for Vaxart After Its Massive Meltdown?